Menu
Home

Manuscripts

June 1, 2025

Challenges in analyzing real-world evidence: Analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study

ESMO Real World Data and Digital Oncology
Tran B
Read More >
May 6, 2025

Real-world clinical characteristics, treatment patterns, and clinical outcomes in US patients with stage I-III resected NSCLC without known EGFR mutations: The RESECT Study

Drugs Real World Outcomes
Gray JE
Read More >
February 28, 2025

Biomarker testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data

JTO Clinical and Research Reports
Behera M
Read More >
January 31, 2025

Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancer

Bladder Cancer Advocacy Network

Callihan, EB

Read More >
December 19, 2024

Racial disparities in clinical trial enrollment among patients diagnosed with prostate cancer: A population-based cohort of oncology practices

Advances in Urology
Wiesen BM et al
Read More >
November 21, 2024

Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology database

Prostate Cancer and Prostatic Diseases
Eule CJ et al
Read More >
August 26, 2024

Treatment intensification in metastatic hormone-sensitive prostate cancer: An analysis of real-world practice patterns from the CancerLinQ database

Urologic Oncology
Eule CJ et al
Read More >
June 25, 2024

EGFR mutation testing, treatment and survival in stage I–III non-small-cell lung cancer: CancerLinQ Discovery database retrospective analysis

Future Oncology
Muthusamy B et al
Read More >
June 19, 2024

Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer

Cancer Medicine
Sukumar JS et al
Read More >

Abstracts

May 30, 2025

Real-world side effects of targeted therapies: High-throughput association studies leveraging the CancerLinq Discovery lung cancer database

ASCO Annual Meeting 2025
Vento J
Read More >
May 30, 2025

Survival impact of adjuvant chemotherapy regimens for small (T1mi/a/b), node-negative (pN0), triple-negative breast cancer (TNBC)

ASCO Annual Meeting 2025
Johnson K
Read More >
December 10, 2024

Social determinants of health (SDOH) and Z code utilization among patients with breast cancer (BC)

SABC 2024

Jones N et al

Read More >
December 10, 2024

Disparities in second breast cancer events and survival persist despite optimal treatment in hormone-receptor positive breast cancer: Analysis of the real-world ASCO CancerLinQ dataset

SABC 2024
Kantor O et al
Read More >
May 23, 2024

Electronic clinical quality measure (eCQM) concordance and quality care disparities among patients with breast cancer (BC).

ASCO Annual Meeting 2024
Jones N et al
Read More >
May 23, 2024

Predicting real-world overall survival for post-operative pancreatic ductal adenocarcinoma: An ASCO CancerLinQ Discovery analysis.

ASCO Annual Meeting 2024
Sohail Ahmed K et al
Read More >
May 23, 2024

Disparities in patients with HER2-positive breast cancer receiving optimal treatment: Analysis of the real-world ASCO CancerLinQ dataset.

ASCO Annual Meeting 2024
Kantor O et al
Read More >
May 1, 2024

MP51-18: Population-based trends and outcomes for cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States

AUA Annual Meeting 2024
Wiesen B et al
Read More >
May 1, 2024

MP31-17: Variation in genomic testing amongst localized prostate cancer patients undergoing radical prostatectomy or radiation therapy: Results from a population-based cohort

AUA Annual Meeting 2024
Wiesen B et al
Read More >